Viewing Study NCT07169318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2026-02-24 @ 4:54 PM
Study NCT ID: NCT07169318
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Double-Blind View
None First-in-Human View
None Food-Effect Study View
None Influenza View
None Multiple Ascending Dose View
None Nucleoprotein View
None Placebo-Controlled View
None Randomized View
None Safety View
None Single Ascending Dose View
None vnt-101 View